Detalles de la búsqueda
1.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol;
203(5): 781-791, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697469
2.
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
Br J Haematol;
196(1): 136-145, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34496035
3.
The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML.
Blood;
136(5): 596-609, 2020 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270193
4.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol;
108(5): 437-445, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122325
5.
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
Br J Haematol;
193(4): 779-791, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33876423
6.
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Biol Blood Marrow Transplant;
24(6): 1209-1215, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474870
7.
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Br J Haematol;
181(6): 782-790, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741758
8.
The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells.
Blood;
123(23): 3622-34, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24755409
9.
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib.
Blood;
123(23): 3574-7, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24687085
10.
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Biol Blood Marrow Transplant;
21(8): 1437-44, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865648
11.
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis.
Leukemia;
37(12): 2426-2435, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848633
12.
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Br J Haematol;
158(2): 174-185, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22640008
13.
Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate.
Blood;
116(12): 2112-21, 2010 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20574046
14.
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.
Leukemia;
36(10): 2443-2452, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35999259
15.
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population.
Clin Lymphoma Myeloma Leuk;
21(7): 476-482, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33814336
16.
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant;
16(5): 639-46, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20005967
17.
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.
Blood;
112(12): 4639-45, 2008 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18723428
18.
Two cases of platelet transfusion refractoriness associated with anti-CD36.
Transfusion;
50(12): 2638-42, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20561295
19.
Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors.
Cell Stem Cell;
27(1): 110-124.e9, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32413332
20.
Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort.
Clin Lymphoma Myeloma Leuk;
20(7): e427-e436, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32201130